Literature DB >> 11330964

Breast cancer risk assessment in indigent women at a public hospital.

N R Abu-Rustum1, H Herbolsheimer.   

Abstract

OBJECTIVES: The aims of this study were to estimate the 5-year breast cancer risk in indigent women presenting to the gynecology clinic at a public hospital and to determine whether routine use of the computerized Gail model for screening in this population identifies individuals at increased risk.
METHODS: A prospective study was performed over 1-year period (7/99-7/00) of women presenting to the gynecology and gynecologic oncology clinics at a public hospital. All women ages 35-60 years with no personal history of breast cancer were offered testing utilizing the computerized Gail model provided by the National Cancer Institute. Age, race, age at menarche, age at first live birth, number of first-degree relatives with breast cancer, number of breast biopsies, and number of breast biopsies diagnosed as atypical hyperplasia were documented. A calculated 5-year risk > or =1.67% was considered high-risk.
RESULTS: In all, 319 women enrolled, 121 (38%) with a history of gynecologic cancer and 198 (62%) without. The mean age was 46.9 years (range 35-60), and 28 (8.8%) patients had at least one first-degree relative with breast cancer. Ethnicity included 206 (65%) African American, 52 (16%) Caucasian, 45 (14%) Hispanic, and 16 (5%) oriental. Eight (2.5%) women had a 5-year risk > or =1.67%. The mean 5-year risk for all patients was 0.68% (0.55% for African American versus 0.90% for Caucasian/other, P < 0.001).
CONCLUSION: Estimating 5-year breast cancer risk using the Gail model in indigent women may identify individuals at increased risk. Compared to other patients, African American women appeared to have a lower estimated 5-year risk according to the currently available model. The routine utilization of the Gail model deserves further investigation in the indigent minority population. Copyright 2001 Academic Press.

Entities:  

Mesh:

Year:  2001        PMID: 11330964     DOI: 10.1006/gyno.2001.6160

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  13 in total

1.  Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.

Authors:  Laura L Reimers; Parijatham S Sivasubramanian; Dawn Hershman; Mary Beth Terry; Heather Greenlee; Julie Campbell; Kevin Kalinsky; Matthew Maurer; Ramona Jayasena; Rossy Sandoval; Maria Alvarez; Katherine D Crew
Journal:  Breast J       Date:  2015-04-16       Impact factor: 2.431

2.  Addressing barriers to uptake of breast cancer chemoprevention for patients and providers.

Authors:  Katherine D Crew
Journal:  Am Soc Clin Oncol Educ Book       Date:  2015

3.  Tamoxifen vs Raloxifene vs Exemestane for Chemoprevention.

Authors:  Laura Reimers; Katherine D Crew
Journal:  Curr Breast Cancer Rep       Date:  2012-09-01

4.  Identifying Women at High Risk for Breast Cancer Using Data From the Electronic Health Record Compared With Self-Report.

Authors:  Xinyi Jiang; Julia E McGuinness; Margaret Sin; Thomas Silverman; Rita Kukafka; Katherine D Crew
Journal:  JCO Clin Cancer Inform       Date:  2019-03

5.  Perceived risk of breast cancer among Latinas attending community clinics: risk comprehension and relationship with mammography adherence.

Authors:  Kristi D Graves; Elmer Huerta; Jennifer Cullen; Elizabeth Kaufman; Vanessa Sheppard; George Luta; Claudine Isaacs; Marc D Schwartz; Jeanne Mandelblatt
Journal:  Cancer Causes Control       Date:  2008-08-15       Impact factor: 2.506

6.  Gail model risk assessment and risk perceptions.

Authors:  John M Quillin; Elizabeth Fries; Donna McClish; Ellen Shaw de Paredes; Joann Bodurtha
Journal:  J Behav Med       Date:  2004-04

7.  Breast cancer risk assessment in socioeconomically disadvantaged urban communities.

Authors:  Chyongchiou Jeng Lin; Bruce Block; Mary Patricia Nowalk; Mattie Woods; Edmund M Ricci; Keith H Morgenlander; Dwight E Heron
Journal:  J Natl Med Assoc       Date:  2007-07       Impact factor: 1.798

8.  Assessment of performance of the Gail model for predicting breast cancer risk: a systematic review and meta-analysis with trial sequential analysis.

Authors:  Xin Wang; Yubei Huang; Lian Li; Hongji Dai; Fengju Song; Kexin Chen
Journal:  Breast Cancer Res       Date:  2018-03-13       Impact factor: 6.466

9.  How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention?

Authors:  Katherine D Crew; Kathy S Albain; Dawn L Hershman; Joseph M Unger; Shelly S Lo
Journal:  NPJ Breast Cancer       Date:  2017-05-19

10.  Mammography screening after risk-tailored messages: the women improving screening through education and risk assessment (WISER) randomized, controlled trial.

Authors:  Joann Bodurtha; John M Quillin; Kelly A Tracy; Joseph Borzelleca; Donna McClish; Diane Baer Wilson; Resa M Jones; Julie Quillin; Deborah Bowen
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.